Creo Medical Group Future Growth

Future criteria checks 0/6

Creo Medical Group's revenue is forecast to decline at 4.9% per annum while its annual earnings are expected to grow at 41% per year. EPS is expected to grow by 45.6% per annum. Return on equity is forecast to be -14.7% in 3 years.

Key information

41.0%

Earnings growth rate

45.6%

EPS growth rate

Medical Equipment earnings growth14.3%
Revenue growth rate-4.9%
Future return on equity-14.7%
Analyst coverage

Low

Last updated24 Oct 2024

Recent future growth updates

Recent updates

Earnings and Revenue Growth Forecasts

BST:1RC - Analysts future estimates and past financials data (GBP Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/202628-11-14-132
12/31/202532-11-16-153
12/31/202434-19-2-163
6/30/202430-22-22-20N/A
3/31/202431-22-22-21N/A
12/31/202331-22-23-22N/A
9/30/202330-23-24-22N/A
6/30/202329-25-25-23N/A
3/31/202328-26-27-24N/A
12/31/202227-27-28-25N/A
9/30/202227-28-33-27N/A
6/30/202226-28-38-30N/A
3/31/202226-26-35-28N/A
12/31/202125-25-32-26N/A
9/30/202124-23-26-22N/A
6/30/202122-21-19-19N/A
3/31/202116-21-18-18N/A
12/31/20209-20-17-16N/A
9/30/20205-19-17-16N/A
6/30/20200-17-17-16N/A
3/31/20200-17-15-14N/A
12/31/20190-16-13-12N/A
6/30/20190-13-14-13N/A
3/31/20190-12-12-11N/A
12/31/2018N/A-10-10-10N/A
12/31/20170-8N/A-9N/A
9/30/20170-8N/A-8N/A
6/30/2017N/A-8N/A-7N/A
6/30/20161-5N/A-5N/A
2/29/20161-3N/A-3N/A
2/28/2015N/A-2N/A-2N/A
2/28/20141-2N/A-1N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 1RC is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: 1RC is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: 1RC is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: 1RC's revenue is expected to decline over the next 3 years (-4.9% per year).

High Growth Revenue: 1RC's revenue is forecast to decline over the next 3 years (-4.9% per year).


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: 1RC is forecast to be unprofitable in 3 years.


Discover growth companies